Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 2 Pyrrolidone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel NiMnAl@NC catalyst enables high-yield, green synthesis of 5-methyl-N-aryl-2-pyrrolidone from biomass, offering significant cost and supply chain advantages.
Patent CN110294701A offers solvent-free synthesis. Reduces safety risks and cost. Reliable fine chemical intermediate supplier for scale-up.
Patent CN114686451B reveals mutant amine dehydrogenase for high-purity lactam production. Offers cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN114686451A discloses amine dehydrogenase mutants for high-yield production. Offers cost reduction in pharma intermediate manufacturing with >99% ee.
Novel low-cost route for Oxiracetam using chloroacetoacetic ester. High yield, simple process suitable for commercial scale-up and cost reduction.
Novel metal halide catalysis eliminates high-pressure hydrogenation risks. Delivers high-purity lactam compounds with significant cost reduction in API manufacturing and enhanced supply chain reliability for global partners.
Novel silver-catalyzed cyclization for 4-methylenepyrrolidine-2-thiones. Efficient, atom-economical route for high-purity pharmaceutical intermediates with scalable supply chain benefits.
Novel one-pot synthesis for Teneligliptin intermediate offers high purity and cost efficiency for pharmaceutical manufacturing supply chains globally.
Patent CN111393419B reveals a catalyst-free radical cyclization method for ether-substituted 2-pyrrolidones, offering high atom economy and simplified manufacturing for pharmaceutical intermediates.
Novel nickel-catalyzed carbonylation for 2-pyrrolidone derivatives. Cost-effective, mild conditions, scalable pharmaceutical intermediate manufacturing solution.
Novel nickel-catalyzed carbonylation method for 2-pyrrolidone derivatives offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel nickel-catalyzed carbonylation method for 2-pyrrolidone derivatives offering significant cost reduction and enhanced supply chain reliability for global pharmaceutical intermediates.
Novel nickel-catalyzed carbonylation method for 2-pyrrolidone derivatives offers cost-effective and scalable pharmaceutical intermediate manufacturing solutions for global supply chains.
Patent CN119874591B details nickel-catalyzed carbonylation for 2-pyrrolidone derivatives offering cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Novel nickel-catalyzed carbonylation method for 2-pyrrolidone derivatives offering cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel nickel-catalyzed method for 2-pyrrolidone derivatives offers cost-effective scalable synthesis for pharmaceutical intermediates supply chain optimization and high purity standards.
Patent CN119874591B reveals a nickel-catalyzed carbonylation method for 2-pyrrolidone derivatives, offering cost-effective and scalable pharmaceutical intermediate manufacturing solutions.
Novel nickel-catalyzed carbonylation method for 2-pyrrolidone derivatives offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN102351726A reveals a high-yield baclofen intermediate synthesis using ultrafine potassium carbonate, eliminating toxic solvents and cryogenic conditions for cost-effective manufacturing.
Patent CN119874591B reveals nickel-catalyzed synthesis offering cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.